Institutional Ownership Kiniksa Pharmaceuticals, Ltd. (KNSA)
This table provides information about the institutional ownership of Kiniksa Pharmaceuticals, Ltd. (KNSA). We have compiled data on the 8 institutions that hold shares in the stock, with a total of 1.95 Million shares, which have been reported (via 13F filing form) to have a value of $40 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
1,517,123
shares
|
$31.2 Million
0.03% of portfolio
|
Q2 2023
Added 5.13%
|
|
|
Spearhead Capital Advisors, LLC
Wellington, FL |
Nov 08, 2022 Q3 2022 |
202,580
shares
|
$4.17 Million
2.82% of portfolio
|
Q3 2022
Reduced 13.8%
|
|
|
Harbor Capital Advisors, Inc.
|
Oct 29, 2024 Q3 2024 |
97,543
shares
|
$2.01 Million
0.11% of portfolio
|
Q3 2024
New holding
|
|
|
Putnam Investments LLC
Boston, MA |
Feb 14, 2024 Q4 2023 |
39,486
shares
|
$813,016
0.0% of portfolio
|
Q4 2023
Reduced 3.08%
|
|
|
Birchview Capital, LP
Burlington, VT |
Nov 14, 2024 Q3 2024 |
30,000
shares
|
$617,700
0.69% of portfolio
|
Q3 2021
Added 50.0%
|
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
28,924
shares
|
$595,545
0.0% of portfolio
|
Q4 2023
Added 13.84%
|
|
|
Virginia Retirement Systems Et Al
Richmond, VA |
Jan 02, 2024 Q3 2023 |
25,200
shares
|
$518,868
0.0% of portfolio
|
Q3 2023
Reduced 21.98%
|
|
|
Exane Derivatives
|
Jul 12, 2022 Q2 2022 |
9,496
shares
|
$195,522
0.06% of portfolio
|
Q1 2022
Reduced 7.87%
|